speb/financial-data huggingface dataset:
BLND balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -16963000.00
BLND income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -150990.00
BLND income_statement (quarterly, 2025-03-31) — Tax Provision: 30000.00
BLND income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
BLND balance_sheet (quarterly, 2025-03-31) — Total Assets: 188266000.00
BLND balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -16886000.00
BLND balance_sheet (quarterly, 2025-03-31) — Total Debt: 1713000.00
BLND balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -16886000.00
BLND income_statement (quarterly, 2025-03-31) — Total Expenses: 34106000.00
BLND balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 205152000.00
BLND balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 48322000.00
BLND balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 147059000.00
BLND income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -7980000.00
BLND income_statement (quarterly, 2025-03-31) — Total Unusual Items: -719000.00
BLND income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -719000.00
BLND balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 291000.00
BLND balance_sheet (quarterly, 2025-03-31) — Working Capital: 81851000.00
BLND income_statement (quarterly, 2025-06-30) — +Operating Expense: 27901000.00
BLND income_statement (quarterly, 2025-06-30) — +Total Revenue: 31523000.00
BLND balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1201000.00
BLND balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 14962000.00
BLND balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2182000.00
BLND balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1377769000.00
BLND balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -99000.00
BLND balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 6440000.00
BLND income_statement (quarterly, 2025-06-30) — Basic Average Shares: 259211000.00
BLND income_statement (quarterly, 2025-06-30) — Basic EPS: -0.04
BLND cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 67979000.00
BLND cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4007000.00
BLND balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2379000.00
BLND balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
BLND balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 36499000.00
BLND balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 88300000.00
BLND cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3651000.00
BLND cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -11069000.00
BLND cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -5018000.00
BLND cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Investing Activities: -36000.00
BLND cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: -1076000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -1465000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1195000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -783000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -352000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Payable: -1465000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2660000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -2126000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Receivables: -4266000.00
BLND cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -10187000.00
BLND cash_flow (quarterly, 2025-06-30) — Changes In Cash: -20850000.00
BLND balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
BLND balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -22565000.00
BLND cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -1550000.00
BLND income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8218000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 9183000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Assets: 126830000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 958000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 958000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 1675000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 32746000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 32746000.00
BLND balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 52743000.00
BLND cash_flow (quarterly, 2025-06-30) — Depreciation: 762000.00
BLND cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 762000.00
BLND cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 762000.00
BLND income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 259211000.00
BLND income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.04
BLND income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -11021000.00
BLND income_statement (quarterly, 2025-06-30) — EBIT: -3606000.00
BLND income_statement (quarterly, 2025-06-30) — EBITDA: -2844000.00
BLND cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 0.00
BLND cash_flow (quarterly, 2025-06-30) — End Cash Position: 47129000.00
BLND cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3651000.00
BLND cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -10101000.00
BLND balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 514000.00
BLND income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 13619000.00
BLND balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 73000.00
BLND balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 15061000.00
BLND balance_sheet (quarterly, 2025-06-30) — Gross PPE: 25141000.00
BLND income_statement (quarterly, 2025-06-30) — Gross Profit: 23305000.00
BLND cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 199000.00
BLND income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
BLND income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
BLND cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
BLND balance_sheet (quarterly, 2025-06-30) — Invested Capital: -22565000.00
BLND cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -11105000.00
BLND balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 13801000.00
BLND balance_sheet (quarterly, 2025-06-30) — Liabilities Heldfor Sale Non Current: 858000.00
BLND balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1421000.00
BLND balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1421000.00
BLND balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 13801000.00
BLND balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 23361000.00
BLND balance_sheet (quarterly, 2025-06-30) — Minority Interest: 0.00
BLND income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
BLND cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -1550000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income: -6645000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -11021000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3647000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -2998000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -6645000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3647000.00
BLND cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3360000.00
BLND income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -6645000.00
BLND income_statement (quarterly, 2025-06-30) — Net Interest Income: 0.00
BLND cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -7062000.00
BLND income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 0.00
BLND cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -2531000.00
BLND balance_sheet (quarterly, 2025-06-30) — Net PPE: 22959000.00
BLND cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4007000.00
BLND balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -22638000.00
BLND balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 3399000.00
BLND balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 10500000.00
BLND income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2816000.00
BLND income_statement (quarterly, 2025-06-30) — Normalized Income: -3624880.00
BLND cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -6094000.00
BLND income_statement (quarterly, 2025-06-30) — Operating Income: -4596000.00
BLND income_statement (quarterly, 2025-06-30) — Operating Revenue: 31523000.00
BLND balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 260051000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2889000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 5801000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 514000.00
BLND income_statement (quarterly, 2025-06-30) — Other Gand A: 13619000.00
BLND income_statement (quarterly, 2025-06-30) — Other Income Expense: 990000.00
BLND cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 253000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5510000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 42000.00
BLND income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1018000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Properties: 1780000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1294000.00
BLND balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 51801000.00
BLND income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 4376000.00
BLND balance_sheet (quarterly, 2025-06-30) — Payables: 1201000.00
BLND balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 10384000.00
BLND balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 2854000.00
BLND balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 150241000.00
BLND balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 6247000.00
BLND income_statement (quarterly, 2025-06-30) — Pretax Income: -3606000.00
BLND cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 430000.00
BLND cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -15873000.00
BLND cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4007000.00
BLND balance_sheet (quarterly, 2025-06-30) — Receivables: 16256000.00
BLND income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8218000.00
BLND income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 762000.00
BLND cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1550000.00
BLND income_statement (quarterly, 2025-06-30) — Research And Development: 7332000.00
BLND balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 5023000.00
BLND income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 28000.00
BLND balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1400850000.00
BLND cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 8811000.00
BLND income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 6950000.00
BLND income_statement (quarterly, 2025-06-30) — Selling General And Administration: 20569000.00
BLND balance_sheet (quarterly, 2025-06-30) — Share Issued: 260051000.00
BLND income_statement (quarterly, 2025-06-30) — Special Income Charges: -28000.00
BLND cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7514000.00
BLND balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -22565000.00
BLND balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -22638000.00
BLND income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -5880.00
BLND income_statement (quarterly, 2025-06-30) — Tax Provision: 41000.00
BLND income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
BLND balance_sheet (quarterly, 2025-06-30) — Total Assets: 183072000.00
BLND balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -22565000.00
BLND balance_sheet (quarterly, 2025-06-30) — Total Debt: 2379000.00
BLND balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -22565000.00
BLND income_statement (quarterly, 2025-06-30) — Total Expenses: 36119000.00
BLND balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 205637000.00
BLND balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 56242000.00
BLND balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 152894000.00
BLND income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -4624000.00
BLND income_statement (quarterly, 2025-06-30) — Total Unusual Items: -28000.00
BLND income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -28000.00
BLND balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 332000.00
BLND balance_sheet (quarterly, 2025-06-30) — Working Capital: 74087000.00
BLND income_statement (quarterly, 2025-09-30) — +Operating Expense: 29274000.00
BLND income_statement (quarterly, 2025-09-30) — +Total Revenue: 32860000.00
BLND balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 772000.00
BLND balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12201000.00
BLND balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3226000.00
BLND balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1375276000.00
BLND balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -112000.00
BLND balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 6427000.00
BLND income_statement (quarterly, 2025-09-30) — Basic Average Shares: 259631000.00
BLND income_statement (quarterly, 2025-09-30) — Basic EPS: 0.03
BLND cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 47129000.00
BLND cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2272000.00
BLND balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1611000.00
BLND balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
BLND balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 55021000.00
BLND balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 77255000.00
BLND cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -6199000.00
BLND cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 27455000.00
BLND cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2733000.00
BLND cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Investing Activities: -62000.00
BLND cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: -757000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -429000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1650000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1236000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -7158000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Payable: -429000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1221000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -3447000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2709000.00
BLND cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -7911000.00
BLND cash_flow (quarterly, 2025-09-30) — Changes In Cash: 17704000.00
BLND balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
BLND balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -12485000.00
BLND cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -5025000.00
BLND income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8404000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 8495000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Assets: 115988000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 305000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 305000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 1757000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 25325000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 25325000.00
BLND balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 45672000.00
BLND cash_flow (quarterly, 2025-09-30) — Depreciation: 1192000.00
BLND cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1192000.00
BLND cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1192000.00
BLND income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 268719000.00
BLND income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.03
BLND income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 7974000.00
BLND income_statement (quarterly, 2025-09-30) — EBIT: 12437000.00
BLND income_statement (quarterly, 2025-09-30) — EBITDA: 13629000.00
BLND cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
BLND cash_flow (quarterly, 2025-09-30) — End Cash Position: 64833000.00
BLND cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -6199000.00
BLND cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5762000.00
BLND balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 555000.00
BLND income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 12879000.00
BLND balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 69000.00
BLND balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 12313000.00
BLND balance_sheet (quarterly, 2025-09-30) — Gross PPE: 27777000.00
BLND income_statement (quarterly, 2025-09-30) — Gross Profit: 24456000.00
BLND cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: -132000.00
BLND income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
BLND income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
BLND cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
BLND balance_sheet (quarterly, 2025-09-30) — Invested Capital: -12485000.00
BLND cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 27393000.00
BLND balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 30380000.00
BLND cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
BLND balance_sheet (quarterly, 2025-09-30) — Liabilities Heldfor Sale Non Current: 160000.00
BLND balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1306000.00
BLND balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1306000.00
BLND cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
BLND balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 30380000.00
BLND balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 26204000.00
BLND balance_sheet (quarterly, 2025-09-30) — Minority Interest: 0.00
BLND income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
BLND cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -5025000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income: 12532000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 7974000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 12410000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 122000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 12532000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 12410000.00
BLND cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 12410000.00
BLND income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 12532000.00
BLND income_statement (quarterly, 2025-09-30) — Net Interest Income: 0.00
BLND cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 29727000.00
BLND cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
BLND cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
BLND income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 0.00
BLND cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1886000.00
BLND balance_sheet (quarterly, 2025-09-30) — Net PPE: 24551000.00
BLND cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2272000.00
BLND cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
BLND balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -12554000.00
BLND balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 3136000.00
BLND balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 10500000.00
BLND income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 13722000.00
BLND income_statement (quarterly, 2025-09-30) — Normalized Income: 12502814.00
BLND cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -3490000.00
BLND income_statement (quarterly, 2025-09-30) — Operating Income: -4818000.00
BLND income_statement (quarterly, 2025-09-30) — Operating Revenue: 32860000.00
BLND balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 260100000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2639000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 6179000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 555000.00
BLND income_statement (quarterly, 2025-09-30) — Other Gand A: 12879000.00
BLND income_statement (quarterly, 2025-09-30) — Other Income Expense: 17255000.00
BLND cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 390000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 4942000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 114000.00
BLND income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 17348000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Properties: 1573000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Receivables: 3135000.00
BLND balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 22234000.00
BLND income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 4558000.00
BLND balance_sheet (quarterly, 2025-09-30) — Payables: 772000.00
BLND balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9267000.00
BLND balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 4596000.00
BLND balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 154799000.00
BLND cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
BLND balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 7551000.00
BLND income_statement (quarterly, 2025-09-30) — Pretax Income: 12437000.00
BLND cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 712000.00
BLND cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -6741000.00
BLND cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2272000.00
BLND balance_sheet (quarterly, 2025-09-30) — Receivables: 15336000.00
BLND income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8404000.00
BLND income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1192000.00
BLND cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
BLND cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -5025000.00
BLND income_statement (quarterly, 2025-09-30) — Research And Development: 8522000.00
BLND balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 5023000.00
BLND income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 93000.00
BLND balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1388318000.00
BLND cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 36468000.00
BLND income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 7873000.00
BLND income_statement (quarterly, 2025-09-30) — Selling General And Administration: 20752000.00
BLND balance_sheet (quarterly, 2025-09-30) — Share Issued: 260100000.00
BLND income_statement (quarterly, 2025-09-30) — Special Income Charges: -93000.00
BLND cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7766000.00
BLND balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -12485000.00
BLND balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -12554000.00
BLND income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -186.00
BLND income_statement (quarterly, 2025-09-30) — Tax Provision: 27000.00
BLND income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Assets: 189566000.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -12485000.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Debt: 1611000.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -12485000.00
BLND income_statement (quarterly, 2025-09-30) — Total Expenses: 37678000.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 202051000.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 73578000.00
BLND balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 156379000.00
BLND income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4911000.00
BLND income_statement (quarterly, 2025-09-30) — Total Unusual Items: -93000.00
BLND income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -93000.00
BLND balance_sheet (quarterly, 2025-09-30) — Working Capital: 70316000.00
BLND income_statement (annual, 2025-12-31) — +Operating Expense: 112031000.00
BLND income_statement (quarterly, 2025-12-31) — +Operating Expense: 28923000.00
BLND income_statement (annual, 2025-12-31) — +Total Revenue: 123585000.00
BLND income_statement (quarterly, 2025-12-31) — +Total Revenue: 32432000.00
BLND balance_sheet (annual, 2025-12-31) — Accounts Payable: 1826000.00
BLND balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1826000.00
BLND balance_sheet (annual, 2025-12-31) — Accounts Receivable: 8786000.00
BLND balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 8786000.00
BLND balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4429000.00
BLND balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4429000.00
BLND balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1360704000.00
BLND balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1360704000.00
BLND balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -112000.00
BLND balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -112000.00
BLND balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 5640000.00
BLND balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 5640000.00
BLND balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 30380000.00
BLND balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 30380000.00
BLND income_statement (annual, 2025-12-31) — Basic Average Shares: 258949000.00
BLND income_statement (quarterly, 2025-12-31) — Basic Average Shares: 258121000.00
BLND income_statement (annual, 2025-12-31) — Basic EPS: -0.10
BLND income_statement (quarterly, 2025-12-31) — Basic EPS: -0.03
BLND cash_flow (annual, 2025-12-31) — Beginning Cash Position: 49537000.00
BLND cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 64833000.00
BLND cash_flow (annual, 2025-12-31) — Capital Expenditure: -11593000.00
BLND cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1001000.00
BLND balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1477000.00
BLND balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1477000.00
BLND balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
BLND balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
BLND balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 43578000.00
BLND balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 43578000.00
BLND balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 68317000.00
BLND balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 68317000.00
BLND cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -32587000.00
BLND cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -17561000.00
BLND cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 18731000.00
BLND cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1241000.00
BLND cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 14398000.00
BLND cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2338000.00
BLND cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: -195000.00
BLND cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Investing Activities: -13000.00
BLND cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: -2886000.00
BLND cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: -1358000.00
BLND cash_flow (annual, 2025-12-31) — Change In Account Payable: 206000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1054000.00
BLND cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 807000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -159000.00
BLND cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1317000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -370000.00
BLND cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1184000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -6229000.00
BLND cash_flow (annual, 2025-12-31) — Change In Payable: 206000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Payable: 1054000.00
BLND cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1013000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 895000.00
BLND cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -5430000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -721000.00
BLND cash_flow (annual, 2025-12-31) — Change In Receivables: 5760000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Receivables: 3415000.00
BLND cash_flow (annual, 2025-12-31) — Change In Working Capital: -1158000.00
BLND cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3010000.00
BLND cash_flow (annual, 2025-12-31) — Changes In Cash: -2539000.00
BLND cash_flow (quarterly, 2025-12-31) — Changes In Cash: -17835000.00
BLND balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
BLND balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
BLND balance_sheet (annual, 2025-12-31) — Common Stock Equity: -30473000.00
BLND balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -30473000.00
BLND cash_flow (annual, 2025-12-31) — Common Stock Payments: -24870000.00
BLND cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -15727000.00
BLND income_statement (annual, 2025-12-31) — Cost Of Revenue: 32418000.00
BLND income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 7985000.00
BLND balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 8357000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8357000.00
BLND balance_sheet (annual, 2025-12-31) — Current Assets: 97864000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Assets: 97864000.00
BLND balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 254000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 254000.00
BLND balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 254000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 254000.00
BLND balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 1812000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 1812000.00
BLND balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 19385000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 19385000.00
BLND balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 19385000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 19385000.00
BLND balance_sheet (annual, 2025-12-31) — Current Liabilities: 39454000.00
BLND balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 39454000.00
BLND cash_flow (annual, 2025-12-31) — Depreciation: 3819000.00
BLND cash_flow (quarterly, 2025-12-31) — Depreciation: 1381000.00
BLND cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3819000.00
BLND cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1381000.00
BLND cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3819000.00
BLND cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1381000.00
BLND income_statement (annual, 2025-12-31) — Diluted Average Shares: 258949000.00
BLND income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 258121000.00
BLND income_statement (annual, 2025-12-31) — Diluted EPS: -0.10
BLND income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.03
BLND income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -25887000.00
BLND income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -8154000.00
BLND income_statement (annual, 2025-12-31) — EBIT: -878000.00
BLND income_statement (quarterly, 2025-12-31) — EBIT: -3130000.00
BLND income_statement (annual, 2025-12-31) — EBITDA: 2941000.00
BLND income_statement (quarterly, 2025-12-31) — EBITDA: -1749000.00
BLND cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
BLND cash_flow (annual, 2025-12-31) — End Cash Position: 46998000.00
BLND cash_flow (quarterly, 2025-12-31) — End Cash Position: 46998000.00
BLND cash_flow (annual, 2025-12-31) — Financing Cash Flow: -32587000.00
BLND cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -17561000.00
BLND cash_flow (annual, 2025-12-31) — Free Cash Flow: -81000.00
BLND cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -21000.00
BLND cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -17405000.00
BLND cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -825000.00
BLND cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
BLND balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 597000.00
BLND balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 597000.00
BLND income_statement (annual, 2025-12-31) — General And Administrative Expense: 50115000.00
BLND income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 12392000.00
BLND balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 8898000.00
BLND balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 8898000.00
BLND balance_sheet (annual, 2025-12-31) — Gross PPE: 28820000.00
BLND balance_sheet (quarterly, 2025-12-31) — Gross PPE: 28820000.00
BLND income_statement (annual, 2025-12-31) — Gross Profit: 91167000.00
BLND income_statement (quarterly, 2025-12-31) — Gross Profit: 24447000.00
BLND cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 389000.00
BLND cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 189000.00
BLND income_statement (annual, 2025-12-31) — Interest Expense: 0.00
BLND income_statement (quarterly, 2025-12-31) — Interest Expense: 0.00
BLND income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 0.00
BLND income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 0.00
BLND cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
BLND balance_sheet (annual, 2025-12-31) — Invested Capital: -30473000.00
BLND balance_sheet (quarterly, 2025-12-31) — Invested Capital: -30473000.00
BLND cash_flow (annual, 2025-12-31) — Investing Cash Flow: 18536000.00
BLND cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1254000.00
BLND balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 30380000.00
BLND balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 30380000.00
BLND balance_sheet (annual, 2025-12-31) — Investments And Advances: 40072000.00
BLND balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 40072000.00
BLND cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
BLND balance_sheet (annual, 2025-12-31) — Liabilities Heldfor Sale Non Current: 154000.00
BLND balance_sheet (quarterly, 2025-12-31) — Liabilities Heldfor Sale Non Current: 154000.00
BLND balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1223000.00
BLND balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1223000.00
BLND balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1223000.00
BLND balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1223000.00
BLND cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
BLND balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 9692000.00
BLND balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 9692000.00
BLND balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 27426000.00
BLND balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 27426000.00
BLND balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
BLND balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
BLND income_statement (annual, 2025-12-31) — Minority Interests: -1072000.00
BLND income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
BLND cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
BLND cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -24870000.00
BLND cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -15727000.00
BLND income_statement (annual, 2025-12-31) — Net Income: -8055000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income: -3458000.00
BLND income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -25887000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8154000.00
BLND income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1127000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3281000.00
BLND income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -5856000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: -177000.00
BLND income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8055000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3458000.00
BLND income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2199000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3281000.00
BLND cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -1127000.00
BLND cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3281000.00
BLND income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -6983000.00
BLND income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3458000.00
BLND income_statement (annual, 2025-12-31) — Net Interest Income: 0.00
BLND income_statement (quarterly, 2025-12-31) — Net Interest Income: 0.00
BLND cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 30324000.00
BLND cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -240000.00
BLND cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BLND cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BLND income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 0.00
BLND income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 0.00
BLND cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -9369000.00
BLND cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1981000.00
BLND balance_sheet (annual, 2025-12-31) — Net PPE: 24391000.00
BLND balance_sheet (quarterly, 2025-12-31) — Net PPE: 24391000.00
BLND cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -11593000.00
BLND cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1001000.00
BLND cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
BLND balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -30473000.00
BLND balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -30473000.00
BLND balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 3425000.00
BLND balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 3425000.00
BLND balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 0.00
BLND balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 0.00
BLND income_statement (annual, 2025-12-31) — Normalized EBITDA: 3812000.00
BLND income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1718000.00
BLND income_statement (annual, 2025-12-31) — Normalized Income: -1510910.00
BLND income_statement (quarterly, 2025-12-31) — Normalized Income: -3256510.00
BLND cash_flow (annual, 2025-12-31) — Operating Cash Flow: 11512000.00
BLND cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 980000.00
BLND cash_flow (annual, 2025-12-31) — Operating Gains Losses: -17405000.00
BLND cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -825000.00
BLND income_statement (annual, 2025-12-31) — Operating Income: -20864000.00
BLND income_statement (quarterly, 2025-12-31) — Operating Income: -4476000.00
BLND income_statement (annual, 2025-12-31) — Operating Revenue: 123585000.00
BLND income_statement (quarterly, 2025-12-31) — Operating Revenue: 32432000.00
BLND balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 256043000.00
BLND balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 256043000.00
BLND balance_sheet (annual, 2025-12-31) — Other Current Assets: 1195000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1195000.00
BLND balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 5077000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 5077000.00
BLND balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 597000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 597000.00
BLND income_statement (annual, 2025-12-31) — Other Gand A: 50115000.00
BLND income_statement (quarterly, 2025-12-31) — Other Gand A: 12392000.00
BLND income_statement (annual, 2025-12-31) — Other Income Expense: 19986000.00
BLND income_statement (quarterly, 2025-12-31) — Other Income Expense: 1346000.00
BLND cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1314000.00
BLND cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 494000.00
BLND balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4293000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4293000.00
BLND balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 192000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 192000.00
BLND income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 20857000.00
BLND income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1377000.00
BLND balance_sheet (annual, 2025-12-31) — Other Properties: 1394000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Properties: 1394000.00
BLND balance_sheet (annual, 2025-12-31) — Other Receivables: 5266000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Receivables: 5266000.00
BLND balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 24739000.00
BLND balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 24739000.00
BLND balance_sheet (annual, 2025-12-31) — Payables: 1826000.00
BLND balance_sheet (quarterly, 2025-12-31) — Payables: 1826000.00
BLND balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10183000.00
BLND balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10183000.00
BLND balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4555000.00
BLND balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4555000.00
BLND balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 159495000.00
BLND balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 159495000.00
BLND income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 17832000.00
BLND cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
BLND cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
BLND balance_sheet (annual, 2025-12-31) — Prepaid Assets: 6848000.00
BLND balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 6848000.00
BLND income_statement (annual, 2025-12-31) — Pretax Income: -878000.00
BLND income_statement (quarterly, 2025-12-31) — Pretax Income: -3130000.00
BLND cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1652000.00
BLND cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 147000.00
BLND cash_flow (annual, 2025-12-31) — Purchase Of Investment: -39485000.00
BLND cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -4995000.00
BLND cash_flow (annual, 2025-12-31) — Purchase Of PPE: -11593000.00
BLND cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1001000.00
BLND balance_sheet (annual, 2025-12-31) — Receivables: 14052000.00
BLND balance_sheet (quarterly, 2025-12-31) — Receivables: 14052000.00
BLND income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 32418000.00
BLND income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 7985000.00
BLND income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3819000.00
BLND income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1381000.00